Mitochondria-associated endoplasmic reticulum membranes microenvironment: Targeting autophagic and apoptotic pathways in cancer therapy

Frontiers in Oncology

Volumn 5, Issue JUL, 2015, Pages

  Patergnani, Simone ^a   Missiroli, Sonia ^a   Marchi, Saverio ^a   Giorgi, Carlotta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Autophagy; Calcium; Cancer; Cell death; MAM

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CASPASE; CHAPERONE; CHLOROQUINE; HYDROXYCHLOROQUINE; METFORMIN; MITOFUSIN 1; MITOFUSIN 2; OKADAIC ACID; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BCL X; PROTEIN KINASE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CELL PERMEABILIZATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM MEMBRANE; GENE MUTATION; INFLAMMATION; MITOCHONDRIAL MEMBRANE; MITOPHAGY; NECROPTOSIS; ONCOGENE; PHOSPHORYLATION; REVIEW; TUMOR GROWTH;

EID: 84940107128     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00173     Document Type: Review

References (107)

1. Baehrecke EH. How death shapes life during development. Nat Rev Mol Cell Biol (2002) 3:779-87. doi:10.1038/nrm931.
2. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell (2011) 147:742-58. doi:10.1016/j.cell.2011.11.045.
3. Yuan J, Kroemer G. Alternative cell death mechanisms in development and beyond. Genes Dev (2010) 24:2592-602. doi:10.1101/gad.1984410.
4. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ (2012) 19:107-20. doi:10.1038/cdd.2011.96.
5. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ (2009) 16:966-75. doi:10.1038/cdd.2009.33.
6. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, et al. Autophagy in malignant transformation and cancer progression. EMBO J (2015) 34:856-80. doi:10.15252/embj.201490784.
7. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 87:99-163. doi:10.1152/physrev.00013.2006.
8. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene (2006) 25:4798-811. doi:10.1038/sj.onc.1209608.
9. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med (2000) 6:513-9. doi:10.1038/74994.
10. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol (2005) 6:268-75. doi:10.1038/nrm1573.
11. Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle (2013) 12:674-83. doi:10.4161/cc.23599.
12. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell (2011) 147:728-41. doi:10.1016/j.cell.2011.10.026.
13. Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res (2014) 24:24-41. doi:10.1038/cr.2013.168.
14. Mizushima N. Autophagy: process and function. Genes Dev (2007) 21:2861-73. doi:10.1101/gad.1599207.
15. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol (2011) 27:107-32. doi:10.1146/annurev-cellbio-092910-154005.
16. Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol (2013) 14:759-74. doi:10.1038/nrm3696.
17. Alers S, Loffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol (2012) 32:2-11. doi:10.1128/MCB.06159-11.
18. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 40:310-22. doi:10.1016/j.molcel.2010.09.026.
19. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov (2012) 11:709-30. doi:10.1038/nrd3802.
20. Wang Z, Choi ME. Autophagy in kidney health and disease. Antioxid Redox Signal (2014) 20:519-37. doi:10.1089/ars.2013.5363.
21. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med (2013) 368:651-62. doi:10.1056/NEJMra1205406.
22. Weidberg H, Shvets E, Elazar Z. Lipophagy: selective catabolism designed for lipids. Dev Cell (2009) 16:628-30. doi:10.1016/j.devcel.2009.05.001.
23. Hardie DG. AMPK and autophagy get connected. EMBO J (2011) 30:634-5. doi:10.1038/emboj.2011.175.
24. Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ (2012) 19:87-95. doi:10.1038/cdd.2011.146.
25. Yonekawa T, Thorburn A. Autophagy and cell death. Essays Biochem (2013) 55:105-17. doi:10.1042/bse0550105.
26. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science (2004) 306:990-5. doi:10.1126/science.1099993.
27. Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol (2015) 4:184-92. doi:10.1016/j.redox.2014.12.003.
28. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, et al. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta (2009) 1793:1524-32. doi:10.1016/j.bbamcr.2009.01.006.
29. Patergnani S, Pinton P. Mitophagy and mitochondrial balance. Methods Mol Biol (2015) 1241:181-94. doi:10.1007/978-1-4939-1875-1_15.
30. Gomes M, Teixeira AL, Coelho A, Araujo A, Medeiros R. The role of inflammation in lung cancer. Adv Exp Med Biol (2014) 816:1-23. doi:10.1007/978-3-0348-0837-8_1.
31. Radons J. The role of inflammation in sarcoma. Adv Exp Med Biol (2014) 816:259-313. doi:10.1007/978-3-0348-0837-8_11.
32. Senol K, Ozkan MB, Vural S, Tez M. The role of inflammation in gastric cancer. Adv Exp Med Biol (2014) 816:235-57. doi:10.1007/978-3-0348-0837-8_10.
33. Rusten TE, Lindmo K, Juhasz G, Sass M, Seglen PO, Brech A, et al. Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K pathway. Dev Cell (2004) 7:179-92. doi:10.1016/j.devcel.2004.07.005.
34. Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med (2005) 11:353-61. doi:10.1016/j.molmed.2005.06.007.
35. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol (2011) 13:1016-23. doi:10.1038/ncb2329.
36. Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, et al. Akt-mediated regulation of autophagy and tumorigenesis through beclin 1 phosphorylation. Science (2012) 338:956-9. doi:10.1126/science.1225967.
37. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell (2005) 122:927-39. doi:10.1016/j.cell.2005.07.002.
38. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy (2008) 4:600-6. doi:10.4161/auto.6260.
39. Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, et al. Ambra1 regulates autophagy and development of the nervous system. Nature (2007) 447:1121-5. doi:10.1038/nature05925.
40. Strappazzon F, Vietri-Rudan M, Campello S, Nazio F, Florenzano F, Fimia GM, et al. Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. EMBO J (2011) 30:1195-208. doi:10.1038/emboj.2011.49.
41. Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M, et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol (2010) 191:155-68. doi:10.1083/jcb.201002100.
42. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 4:e838. doi:10.1038/cddis.2013.350.
43. Poklepovic A, Gewirtz DA. Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer. Autophagy (2014) 10:1478-80. doi:10.4161/auto.29428.
44. Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy (2014) 10:1391-402. doi:10.4161/auto.29119.
45. Chiarini F, Evangelisti C, Mccubrey JA, Martelli AM. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci (2015) 36:124-35. doi:10.1016/j.tips.2014.11.004.
46. Maes H, Kuchnio A, Peric A, Moens S, Nys K, De Bock K, et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell (2014) 26:190-206. doi:10.1016/j.ccr.2014.06.025.
47. Patergnani S, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, et al. Calcium signaling around mitochondria associated membranes (MAMs). Cell Commun Signal (2011) 9:19. doi:10.1186/1478-811X-9-19.
48. Marchi S, Patergnani S, Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta (2014) 1837:461-9. doi:10.1016/j.bbabio.2013.10.015.
49. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, et al. Autophagosomes form at ER-mitochondria contact sites. Nature (2013) 495:389-93. doi:10.1038/nature11910.
50. van Vliet AR, Verfaillie T, Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta (2014) 1843:2253-62. doi:10.1016/j.bbamcr.2014.03.009.
51. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science (1998) 280:1763-6. doi:10.1126/science.280.5370.1763.
52. Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol (2006) 174:915-21. doi:10.1083/jcb.200604016.
53. Vance JE. MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim Biophys Acta (2014) 1841:595-609. doi:10.1016/j.bbalip.2013.11.014.
54. Csordas G, Varnai P, Golenar T, Roy S, Purkins G, Schneider TG, et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell (2010) 39:121-32. doi:10.1016/j.molcel.2010.06.029.
55. Giorgi C, Wieckowski MR, Pandolfi PP, Pinton P. Mitochondria associated membranes (MAMs) as critical hubs for apoptosis. Commun Integr Biol (2011) 4:334-5. doi:10.4161/cib.4.3.15021.
56. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 142:270-83. doi:10.1016/j.cell.2010.06.007.
57. Giorgi C, Missiroli S, Patergnani S, Duszynski J, Wieckowski MR, Pinton P. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Signal (2015) 22:995-1019. doi:10.1089/ars.2014.6223.
58. Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol (2008) 182:685-701. doi:10.1083/jcb.200803137.
59. Yla-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy (2009) 5:1180-5. doi:10.4161/auto.5.8.10274.
60. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell (2010) 141:656-67. doi:10.1016/j.cell.2010.04.009.
61. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Mol Cell (2006) 24:331-9. doi:10.1016/j.molcel.2006.09.013.
62. Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M, et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science (2010) 330:1247-51. doi:10.1126/science.1189157.
63. Khan MT, Wagner L, Yule DI, Bhanumathy C, Joseph SK. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J Biol Chem (2006) 281:3731-7. doi:10.1074/jbc.M509262200.
64. Marchi S, Rimessi A, Giorgi C, Baldini C, Ferroni L, Rizzuto R, et al. Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. Biochem Biophys Res Commun (2008) 375:501-5. doi:10.1016/j.bbrc.2008.07.153.
65. Marchi S, Marinello M, Bononi A, Bonora M, Giorgi C, Rimessi A, et al. Selective modulation of subtype III IP(3)R by Akt regulates ER Ca(2)(+) release and apoptosis. Cell Death Dis (2012) 3:e304. doi:10.1038/cddis.2012.45.
66. Deniaud A, Sharaf El Dein O, Maillier E, Poncet D, Kroemer G, Lemaire C, et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene (2008) 27:285-99. doi:10.1038/sj.onc.1210638.
67. Bononi A, Bonora M, Marchi S, Missiroli S, Poletti F, Giorgi C, et al. Identification of PTEN at the ER and MAMs and its regulation of Ca signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 20(12):1631-43. doi:10.1038/cdd.2013.77.
68. Giorgi C, Bonora M, Missiroli S, Poletti F, Ramirez FG, Morciano G, et al. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget (2014) 6(3):1435-45.
69. Giorgi C, Bonora M, Sorrentino G, Missiroli S, Poletti F, Suski JM, et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc Natl Acad Sci U S A (2015) 112:1779-84. doi:10.1073/pnas.1410723112.
70. Lebiedzinska M, Duszynski J, Rizzuto R, Pinton P, Wieckowski MR. Age-related changes in levels of p66Shc and serine 36-phosphorylated p66Shc in organs and mouse tissues. Arch Biochem Biophys (2009) 486:73-80. doi:10.1016/j.abb.2009.03.007.
71. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell (2005) 122:221-33. doi:10.1016/j.cell.2005.05.011.
72. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science (2007) 315:659-63. doi:10.1126/science.1135380.
73. Rimessi A, Marchi S, Patergnani S, Pinton P. H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene (2014) 33:2329-40. doi:10.1038/onc.2013.192.
74. Banreti A, Lukacsovich T, Csikos G, Erdelyi M, Sass M. PP2A regulates autophagy in two alternative ways in Drosophila. Autophagy (2012) 8:623-36. doi:10.4161/auto.19081.
75. Magnaudeix A, Wilson CM, Page G, Bauvy C, Codogno P, Leveque P, et al. PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins. Neurobiol Aging (2013) 34:770-90. doi:10.1016/j.neurobiolaging.2012.06.026.
76. Yu HC, Lin CS, Tai WT, Liu CY, Shiau CW, Chen KF. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem (2013) 288:18249-59. doi:10.1074/jbc.M112.446385.
77. Buontempo F, Ersahin T, Missiroli S, Senturk S, Etro D, Ozturk M, et al. Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status. Invest New Drugs (2011) 29:1303-13. doi:10.1007/s10637-010-9486-3.
78. Cheng Y, Ren X, Hait WN, Yang JM. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev (2013) 65:1162-97. doi:10.1124/pr.112.007120.
79. Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A (2002) 99:4319-24. doi:10.1073/pnas.261702698.
80. Ramanathan A, Schreiber SL. Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A (2009) 106:22229-32. doi:10.1073/pnas.0912074106.
81. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 8:445-544. doi:10.4161/auto.19496.
82. Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H, et al. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem (2011) 286:7182-9. doi:10.1074/jbc.M110.179390.
83. Rimessi A, Bonora M, Marchi S, Patergnani S, Marobbio CM, Lasorsa FM, et al. Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction. Autophagy (2013) 9:1677-86. doi:10.4161/auto.24795.
84. Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN. Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A (2013) 110:12526-34. doi:10.1073/pnas.1302455110.
85. Billard C. BH3 mimetics: status of the field and new developments. Mol Cancer Ther (2013) 12:1691-700. doi:10.1158/1535-7163.MCT-13-0058.
86. Fu LL, Cheng Y, Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol (2013) 45:921-4. doi:10.1016/j.biocel.2013.02.007.
87. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther (2010) 9:1092-9. doi:10.1158/1535-7163.MCT-09-1186.
88. Leone A, Di Gennaro E, Bruzzese F, Avallone A, Budillon A. New perspective for an old antidiabetic drug: metformin as anticancer agent. Cancer Treat Res (2014) 159:355-76. doi:10.1007/978-3-642-38007-5_21.
89. Gallo A, Ceolotto G, Pinton P, Iori E, Murphy E, Rutter GA, et al. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes (2005) 54:1123-31. doi:10.2337/diabetes.54.4.1123.
90. Tubbs E, Theurey P, Vial G, Bendridi N, Bravard A, Chauvin MA, et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes (2014) 63:3279-94. doi:10.2337/db13-1751.
91. Patergnani S, Marchi S, Rimessi A, Bonora M, Giorgi C, Mehta KD, et al. PRKCB/protein kinase C, beta and the mitochondrial axis as key regulators of autophagy. Autophagy (2013) 9:1367-85. doi:10.4161/auto.25239.
92. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther (2011) 10:1533-41. doi:10.1158/1535-7163.MCT-11-0047.
93. Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov (2014) 13:217-36. doi:10.1038/nrd4236.
94. Kasahara A, Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol (2014) 24:761-70. doi:10.1016/j.tcb.2014.08.005.
95. Chu CT. A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum Mol Genet (2010) 19:R28-37. doi:10.1093/hmg/ddq143.
96. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet (2010) 19:4861-70. doi:10.1093/hmg/ddq419.
97. Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J (2012) 26:2175-86. doi:10.1096/fj.11-196543.
98. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev (2008) 22:1948-61. doi:10.1101/gad.1661708.
99. Yao Z, Jones AW, Fassone E, Sweeney MG, Lebiedzinska M, Suski JM, et al. PGC-1beta mediates adaptive chemoresistance associated with mitochondrial DNA mutations. Oncogene (2013) 32:2592-600. doi:10.1038/onc.2012.259.
100. Canto C, Auwerx J. Calorie restriction: is AMPK a key sensor and effector? Physiology (Bethesda) (2011) 26:214-24. doi:10.1152/physiol.00010.2011.
101. Wenz T. PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life (2009) 61:1051-62. doi:10.1002/iub.261.
102. Huang B, Cheng X, Wang D, Peng M, Xue Z, Da Y, et al. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1alpha signaling. Oncotarget (2014) 5:4732-45.
103. Hoyer-Hansen M, Jaattela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ (2007) 14:1576-82. doi:10.1038/sj.cdd.4402200.
104. Ding WX, Ni HM, Gao W, Hou YF, Melan MA, Chen X, et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem (2007) 282:4702-10. doi:10.1074/jbc.M609267200.
105. Hoyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jaattela M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and beclin 1-mediated autophagic cell death. Cell Death Differ (2005) 12:1297-309. doi:10.1038/sj.cdd.4401651.
106. Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J (2006) 20:756-8. doi:10.1096/fj.05-4305fje.
107. Choi KS. Autophagy and cancer. Exp Mol Med (2012) 44:109-20. doi:10.3858/emm.2012.44.2.033.